Can the degree of tumour angiogenesis can assessed in vivo?

Articles

Oncology Articles

Height linked to risk of prostate cancer
Colorectal screening should start at the age of 50
WHO proposes strategy for prevention and control of cancer in the African region
Antibiotic use linked to increased risk of cancer
Skin cancer may increase risk of other cancers
Prostatectomy improves outcome of some men with prostate cancer over watchful waiting
Many cancer patients found to be using complementary and alternative methods
Family history is a poor predictor of early breast cancer
Researchers locate, image prostate cancer as it spreads to lymph nodes
Hormone therapy does not improve survival in elderly men with prostate cancer
Avoid cancer by eating a Mediterranean diet
Spread the word: there IS another, scalpel-free treatment option for prostate cancer
Researchers find seven biomarkers that may help pinpoint prostate cancer recurrence
The status of breast health management in South Africa
Cancer vaccine could be in the pipeline

Most commented articles

Early treatment the best for patients with moderate to severe rheumatoid arthritis

Can the degree of tumour angiogenesis can assessed in vivo?

Differentiation of angiogenic burden in human cancer xenografts using a perfusion type optical contrast agent (SIDAG).

With the rapid evolvement of fluorescence imaging in oncology, non-targeted fluorochromes are currently under investigation for clinical use. Here we investigated if the degree of tumour angiogenesis can be assessed in vivo by planar and tomographic methods using a perfusion-type cyanine dye (SIDAG).

Read the full document

[14 Mar 2008 07:12]

SEND TO A FRIEND |


Comment on this

Share this page (Tell me more)

muti

del.icio.us

stumbleupon

yahoo

google

facebook

newsvine

Digg

GoGuide